Annual report pursuant to Section 13 and 15(d)

Consolidated Balance Sheets

v3.10.0.1
Consolidated Balance Sheets - USD ($)
Nov. 30, 2018
Nov. 30, 2017
Current Assets    
Cash and cash equivalents $ 6,040,033 $ 6,279,154
Marketable securities 875,689 439,322
Accounts receivable (net of allowance for doubtful accounts of $2,264,848 and $2,098,991, respectively) 5,867,335 5,125,591
Prepaid expenses 461,815 372,152
Inventory, net 16,035,873 314,566
Other current assets 254,465 206,136
Total current assets 29,535,210 12,736,921
Property and Equipment-net 1,493,401 882,382
Other Assets    
Intangible assets, net 1,341,336 226,418
Goodwill 1,941,411 0
Deferred tax assets 7,656,897 10,035,388
Deposits and other assets, net 113,888 28,888
Total other assets 11,361,532 10,290,694
Total assets 42,390,143 23,909,997
Current Liabilities    
Accounts payable 1,261,653 1,928,542
Accrued expenses 2,702,788 2,582,475
Current portion of note payable 3,100,000 2,000,000
Deferred revenue 8,365,284 7,428,829
Total current liabilities 15,429,725 13,939,846
Other Liabilities    
Deferred revenue, net of current portion 20,317,231 15,752,864
Contingent consideration 4,282,975  
Note payable, net of current portion and debt issuance costs 9,843,510 5,295,183
Long-term liability-revenue sharing agreements 1,425,000 1,425,000
Total other liabilities 35,868,716 22,473,047
Total liabilities 51,298,441 36,412,893
Commitments and contingencies (Note 13)
Stockholders' Deficit    
Preferred stock
Common stock ($.01 par value, 20,000,000 authorized; 13,596,409 issued and 7,800,833 outstanding as of November 30, 2018 and 12,899,517 issued and 7,103,941 outstanding as of November 30, 2017) 135,964 128,995
Additional paid-incapital 35,515,382 31,373,048
Treasury stock, at cost (19,571,113) (19,571,113)
Accumulated other comprehensive income 340,984 40,865
Accumulated deficit (25,329,515) (24,474,691)
Total stockholders' deficit (8,908,298) (12,502,896)
Total liabilities and stockholders' deficit 42,390,143 23,909,997
Series A Junior Participating Preferred Stock [Member]    
Stockholders' Deficit    
Preferred stock
Tianhe Stem Cell Biotechnologies Inc [Member]    
Other Assets    
Investment $ 308,000